198 related articles for article (PubMed ID: 20144478)
1. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy.
Dilnawaz F; Singh A; Mohanty C; Sahoo SK
Biomaterials; 2010 May; 31(13):3694-706. PubMed ID: 20144478
[TBL] [Abstract][Full Text] [Related]
2. Iron oxide nanoparticles for sustained delivery of anticancer agents.
Jain TK; Morales MA; Sahoo SK; Leslie-Pelecky DL; Labhasetwar V
Mol Pharm; 2005; 2(3):194-205. PubMed ID: 15934780
[TBL] [Abstract][Full Text] [Related]
3. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
4. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
Ge Y; Zhang Y; Xia J; Ma M; He S; Nie F; Gu N
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):294-301. PubMed ID: 19564099
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
6. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
Kettering M; Zorn H; Bremer-Streck S; Oehring H; Zeisberger M; Bergemann C; Hergt R; Halbhuber KJ; Kaiser WA; Hilger I
Phys Med Biol; 2009 Sep; 54(17):5109-21. PubMed ID: 19661569
[TBL] [Abstract][Full Text] [Related]
7. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.
Acharya S; Dilnawaz F; Sahoo SK
Biomaterials; 2009 Oct; 30(29):5737-50. PubMed ID: 19631377
[TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
[TBL] [Abstract][Full Text] [Related]
9. Amphiphilic comblike polymers enhance the colloidal stability of Fe(3)O(4) nanoparticles.
Kim M; Jung J; Lee J; Na K; Park S; Hyun J
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):236-40. PubMed ID: 19939645
[TBL] [Abstract][Full Text] [Related]
10. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity assessment of superparamagnetic iron-gold core-shell nanoparticles coated with polyglycerol.
Jafari T; Simchi A; Khakpash N
J Colloid Interface Sci; 2010 May; 345(1):64-71. PubMed ID: 20153479
[TBL] [Abstract][Full Text] [Related]
12. The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Dilnawaz F; Singh A; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
Biomaterials; 2012 Apr; 33(10):2936-51. PubMed ID: 22264522
[TBL] [Abstract][Full Text] [Related]
13. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
14. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic gamma-Fe2O3@SiO2 nanoparticles: a novel support for the immobilization of [VO(acac)2].
Pereira C; Pereira AM; Quaresma P; Tavares PB; Pereira E; Araújo JP; Freire C
Dalton Trans; 2010 Mar; 39(11):2842-54. PubMed ID: 20200711
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
19. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: cancer therapy by circumventing the skin barrier.
Rao YF; Chen W; Liang XG; Huang YZ; Miao J; Liu L; Lou Y; Zhang XG; Wang B; Tang RK; Chen Z; Lu XY
Small; 2015 Jan; 11(2):239-47. PubMed ID: 24925046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
